Skip to NavigationSkip to content

peter clark

CDF chair: more treatment reviews to come

NHS image
NHS England, Quarry House

The chair of NHS England’s cancer drugs fund has said there is likely to be more reviews of affordable treatments in future - and refused to rule out cutting more treatments from the fund.

Professor Peter Clark, a medical oncologist in Merseyside, said the current system for deciding which cancer treatments are available on the NHS is “broken - not logical, robust or rational”. 

As a result, it is likely that the treatments that are on the list will be reviewed again before the fund is set to end in 2016. 

Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches